Ideas to Action:

Independent research for global prosperity

Health Technology Assessment

HTA is the systematic assessment of the comparative effectiveness and cost of health technologies and services and can provide the economic and clinical evidence needed for decisions about what products to purchase or services to offer to achieve value for money. Operationalising HTA as a routine component of commodity procurement and provider payment decisions is a priority in many LMICs with emerging National Health Insurance Funds and a consideration amongst global funding conduits such as the GFATM and Gavi as aid budgets shrink and countries transition towards aid independence. Bilateral donors such as DFID have also signalled their commitment to maximising Value for Money of their investment. CGD's work helps inform how HTA systems and processes can be applied to different settings and what the informational and institutional resource requirements for such application may be.